Trial · NCT03092674
Results by group198
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 198
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Survival (OS) (Phase II) | Azacitidine | 6.2 | 95% Confidence Interval 3.9 to 10 | months | |
| Overall Survival (OS) (Phase II) | Azacitidine + Nivolumab | 5.2 | 95% Confidence Interval 1.1 to 13.1 | months | |
| Overall Survival (OS) (Phase II) | Azacitidine +Midostaurin | 7.4 | 95% Confidence Interval 2.9 to 16.4 | months | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine | Acidosis | 1 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine + Nivolumab | Acidosis | 0 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine +Midostaurin | Acidosis | 0 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine | Acute kidney injury | 0 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine + Nivolumab | Acute kidney injury | 1 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine +Midostaurin | Acute kidney injury | 0 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine | Alanine aminotransferase increased | 0 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine + Nivolumab | Alanine aminotransferase increased | 1 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine +Midostaurin | Alanine aminotransferase increased | 0 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine | Anemia | 12 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine + Nivolumab | Anemia | 10 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine +Midostaurin | Anemia | 13 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine | Anorexia | 0 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine + Nivolumab | Anorexia | 0 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine +Midostaurin | Anorexia | 1 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine | Arthralgia | 0 | Participants | |
| Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs | Azacitidine + Nivolumab | Arthralgia | 1 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03092674/results